Candriam Equities L Biotech.I USD Acc/ LU0133360163 /
| NAV9/20/2023 | Chg.-27.8604 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 4,983.7998USD | -0.56% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010 | - | - | - | -1.92 | -12.43 | -5.63 | 3.72 | -0.39 | 10.81 | 2.77 | -2.49 | 6.27 | - |
| 2011 | -0.55 | 0.81 | 6.01 | 4.63 | 3.03 | -1.68 | -3.48 | -7.93 | -6.61 | 8.03 | 0.79 | 1.88 | +3.71% |
| 2012 | 11.93 | 0.47 | 5.85 | 0.64 | -2.06 | 5.60 | 2.44 | 2.00 | 5.23 | -5.87 | 4.49 | -0.94 | +32.74% |
| 2013 | 9.77 | 1.10 | 8.17 | 6.20 | 3.38 | -2.67 | 14.37 | -2.34 | 10.05 | -2.71 | 6.63 | 1.70 | +66.35% |
| 2014 | 8.34 | 7.43 | -9.86 | -5.01 | 2.85 | 10.21 | -3.16 | 11.16 | -1.01 | 9.50 | 2.94 | 0.54 | +36.44% |
| 2015 | 4.81 | 4.62 | 1.96 | -5.03 | 10.84 | 0.64 | 4.25 | -10.88 | -11.30 | 7.89 | 3.41 | 0.49 | +9.42% |
| 2016 | -23.19 | -4.51 | 3.72 | 3.59 | 5.36 | -8.22 | 12.56 | -2.43 | 3.84 | -12.36 | 8.72 | -2.84 | -19.55% |
| 2017 | 5.49 | 6.87 | -0.10 | 1.21 | -3.07 | 9.20 | 2.54 | 6.37 | 0.79 | -6.35 | 0.27 | 1.51 | +26.45% |
| 2018 | 6.86 | -4.68 | -1.91 | -3.10 | 4.66 | 0.96 | 4.81 | 4.27 | -2.01 | -13.94 | 4.21 | -8.55 | -10.16% |
| 2019 | 13.26 | 3.44 | -0.55 | -4.85 | -4.71 | 9.40 | -2.30 | -2.34 | -4.19 | 10.49 | 11.81 | 2.45 | +33.72% |
| 2020 | -5.13 | -1.12 | -4.98 | 12.87 | 9.33 | 1.41 | -2.75 | 0.93 | 0.67 | -2.80 | 9.83 | 3.11 | +21.31% |
| 2021 | 1.89 | -2.52 | -4.20 | 2.80 | -2.19 | 6.44 | -1.38 | 3.98 | -4.16 | 0.24 | -4.30 | 2.46 | -1.64% |
| 2022 | -10.78 | -1.97 | 5.73 | -7.56 | -3.34 | 3.06 | 4.62 | 1.14 | -1.89 | 6.92 | 6.13 | -2.78 | -2.50% |
| 2023 | 3.00 | -5.68 | 0.44 | 2.28 | -1.20 | 1.25 | -0.14 | -0.16 | -2.43 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 14.43% | 13.20% | 17.48% | 21.01% | 23.58% |
| Sharpe ratio | -0.55 | -0.02 | 0.06 | -0.12 | 0.02 |
| Best month | +3.00% | +2.28% | +6.92% | +9.83% | +13.26% |
| Worst month | -5.68% | -2.43% | -5.68% | -10.78% | -13.94% |
| Maximum loss | -10.21% | -6.46% | -11.48% | -30.63% | -30.63% |
| Outperformance | -1.08% | - | -1.94% | +3.07% | +0.98% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,802.2700 | +6.55% | +3.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 196.4300 | -2.35% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,830.4399 | +3.17% | -3.47% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,973.0100 | -1.35% | +13.63% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,079.5701 | -1.86% | +6.29% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 322.4400 | -1.94% | +9.07% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 288.0200 | -1.47% | +15.37% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 181.0200 | +1.47% | -3.93% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,607.4301 | +6.59% | +5.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 4,983.7998 | +4.99% | +4.19% | |
| Candriam Equities L Biotech.V US... | reinvestment | 527.8700 | +5.02% | +0.90% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 175.6800 | +2.96% | -4.17% | |
| Candriam Equities L Biotech.R US... | reinvestment | 235.7200 | +4.98% | +5.78% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 182.1800 | +3.28% | -1.85% | |
| Candriam Equities L Biotech.C US... | reinvestment | 739.1700 | +5.42% | +2.25% | |
| Candriam Equities L Biotech.C US... | paying dividend | 679.1400 | +5.39% | +2.15% |
Performance
| YTD | -2.90% | ||
|---|---|---|---|
| 6 Months | +1.85% | ||
| 1 Year | +4.99% | ||
| 3 Years | +4.19% | ||
| 5 Years | +24.34% | ||
| 10 Years | +119.97% | ||
| Since start | +398.38% | ||
| Year | |||
| 2022 | -2.50% | ||
| 2021 | -1.64% | ||
| 2020 | +21.31% | ||
| 2019 | +33.72% | ||
| 2018 | -10.16% | ||
| 2017 | +26.45% | ||
| 2016 | -19.55% | ||
| 2015 | +9.42% | ||
| 2014 | +36.44% | ||